Navigation Links
MAD: Scientists shed light on braking mechanisms in cellular signaling
Date:6/5/2014

Stanford, CA A team of researchers studying a flowering plant has zeroed in on the way cells manage external signals about prevailing conditions, a capability that is essential for cells to survive in a fluctuating environment.

Researchers at UC Berkeley, the Plant Gene Expression Center, UC San Francisco, and the Carnegie Institution for Science identified a novel mechanism by which the strength of such an external signal is reduced, or attenuated. Their work focuses on the tiny mustard plant Arabidopsis, which is frequently used by scientists as an experimental model. Their findings are published in Science June 6.

Attenuation of signaling is analogous to the brakes on a car. While acceleration is desirable, acceleration without restraint can be disastrous. In this research, Arabidopsis seedlings were taken from subterranean darkness into sunlight, which triggered a response leading to "rapid and extensive" redirection of gene expression, ultimately resulting in familiar green seedlings.

But a brake on this acceleration of new gene expression is also necessary to restabilize the cells at a new equilibrium. The research team discovered a nuclear-localized, bimolecular signaling configuration by which the braking mechanism is directly linked to the accelerator, thereby providing simultaneous acceleration and restraint. By identifying the mechanism involved in this attenuation process, the team's discovery has potential implications ranging from agricultural to cancer research.

Cellular signaling triggered by external cues such as sunlight enables organisms to adapt to the prevailing conditions. When the organism perceives something that requires a response, a series of chemical signals is activated. This signaling is generally very robust at first. But at some point it is necessary to dial it back or turn it off entirelya restraint that falls to different, less-understood signaling pathways. These types of restraint functions are of great importance but poorly understood, as scientists have focused mostly on how the cells get stimulated in the first place.

Light-signaling in Arabidopsis involves the binding of an activated photoreceptor molecule (called phytochrome) to a transcription factor (gene-switch) called PIF. This binding destroys PIF, switching off its target genes. However, the researchers found that in imposing PIF's destruction, phytochrome signs its own death warrant and is simultaneously executed, thus reducing the incoming light-signaling intensity.

"Understanding such molecular mechanisms underlying the light response kinetics is important for engineering crops that can better adapt to environmental fluctuations," said Carnegie's Zhiyong Wang, one of the co-authors.

This bimolecular mutually assured destruction (MAD) mechanism of signaling attenuation appears to represent a new configuration, thus broadening our understanding of the range of mechanisms nature has evolved for this critical function.


'/>"/>

Contact: Zhiyong Wang
zwang@carnegiescience.edu
650-739-4205
Carnegie Institution
Source:Eurekalert

Related medicine news :

1. Scientists generate long-sought molecular map of critical genetic machinery
2. Scripps Florida scientists unravel the molecular secret of short, intense workouts
3. New nanomedicine by NTU and SERI scientists to bring relief to glaucoma patients
4. Scripps Research Institute scientists win $13 million grant in AIDS vaccine effort
5. Mice with mohawks help scientists link autism to 2 biological pathways in brain
6. Temple scientists receive $11.5 million grant for heart failure research
7. TSRI scientists catch misguided DNA-repair proteins in the act
8. Scientists seek answers with space station thyroid cancer study
9. MIPT scientists develop algorithm for anti-aging remedy search
10. Scientists reveal structural secrets of enzyme used to make popular anti-cholesterol drug
11. Scientists slow brain tumor growth in mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Apple Rehab Shelton Lakes , which specializes in the delivery of sub-acute ... of a disaster drill on October 3rd. , Apple Rehab participated with the Shelton ... well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). The LTC-MAP ...
(Date:10/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a ... centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology: